Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
SK Biopharmaceuticals. (326030.KQ) Q4 2025 Earnings
326030.KQ
5
Nov
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
192
901
1,609
2,318
Details
Expected EPS
349
Actual EPS
929
Surprise EPS
580
Surprise Percent
+166.12%
Description
SK Biopharmaceuticals. (326030.KQ) has reported earnings of 929 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login